Ovarian Cancer Clinical Trials in Georgia

Cancer Type = Ovarian Cancer

Cancer Type = Ovarian Cancer

There are currently 16 active Ovarian Cancer clinical trials in Georgia.
1.
A Phase 1b / 2 Open-label Study To Evaluate Safety, Clinical Activity, Pharmacokinetics And Pharmacodynamics Of Avelumab (msb0010718c) In Combination With Other Cancer Immunotherapies In Patients With Advanced Malignancies
Cancer Type
Breast Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT02554812
Protocol IDs
B9991004
NCI-2015-02263
2015-002552-27
JAVELIN MEDLEY
s16-02110
3.
A Phase I / 2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors
Cancer Type
Bladder Cancer, Cervical Cancer, Kidney Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT01968109
Protocol IDs
CA224-020
NCI-2014-00315
2014-002605-38
4.
NCORP Trial
A Phase I / II Study of Ruxolitinib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Cancer Type
Ovarian Cancer
NCI ID
NCT02713386
Protocol IDs
NRG-GY007
NRG-GY007
NCI-2016-00203
NRG-GY007
Treatment Sites (6)
Atlanta Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Georgia Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
University Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
6.
A Phase II Study of MK-3475 (Pembrolizumab) (NSC #776864) + Epacadostat (NSC #766086) in Recurrent Clear Cell Carcinoma of the Ovary
Cancer Type
Ovarian Cancer
NCI ID
NCT03602586
Protocol IDs
NRG-GY016
NRG-GY016
NCI-2018-01561
8.
A Randomised Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours
Cancer Type
Germ Cell Tumor, Ovarian Cancer
NCI ID
NCT02582697
Protocol IDs
AGCT1532
AGCT1532
NCI-2017-00559
13.
NCORP Trial
ATHENA (A Multicenter, Randomized, Double-Blind, Placebo- Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)
Cancer Type
Ovarian Cancer
NCI ID
NCT03522246
Protocol IDs
CO-338-087/GOG-3020/ENGOT-ov45
NCI-2018-01248
Treatment Sites (4)
Atlanta Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Georgia Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
University Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
14.
Phase 1 / 2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination With Pembrolizumab in Advanced Cancer
Cancer Type
Breast Cancer, Cervical Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Ovarian Cancer, Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03674567
Protocol IDs
FLX475-02
NCI-2019-00102
15.
NCORP Trial
Phase II Double Blind Dose Finding Trial of Bupropion versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer
Cancer Type
Breast Cancer, Cervical Cancer, Gynecologic Cancers, Ovarian Cancer
NCI ID
NCT03180294
Protocol IDs
NRG-CC004
NRG-CC004
NRG-CC004
NCI-2017-00344
Treatment Sites (1)
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.